Department of Otolaryngology-Head & Neck Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Department of General Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
JAMA Otolaryngol Head Neck Surg. 2016 Feb;142(2):143-9. doi: 10.1001/jamaoto.2015.3123.
A modified percutaneous dilational tracheostomy (PDT) is a relatively new alternative method of performing PDTs in which tissues overlying the trachea are dissected, but needle entry is still performed blindly. Many centers use bronchoscopy-assisted PDT, but the necessity of bronchoscope assistance for modified PDTs has not been examined. Discontinuing bronchoscopy for this procedure could potentially decrease cost and increase efficiency with similar outcomes compared with bronchoscopy-assisted PDT.
To evaluate the necessity of bronchoscopy in placement of PDT.
DESIGN, SETTING, AND PARTICIPANTS: A single-center, retrospective cohort study of 149 patients who underwent PDT, with or without bronchoscope assistance, was conducted between May 1, 2007, and February 1, 2015, in a tertiary care facility. Data analysis was performed from April 15, 2015, to May 1, 2015.
Modified PDT with or without bronchoscopy.
The primary outcomes of interest were postprocedural complications and length of stay during the hospitalization at which the tracheostomy was placed.
Of the 149 patients who underwent modified PDT during the study period and met the inclusion criteria, 107 were in the no-bronchoscope cohort (66 [61.7%] were men; mean [SD] age, 56.0 [18.7] years) and 42 were in the bronchoscope-assisted cohort (26 [61.9%] were men; mean [SD] age, 58.0 [15.7] years). Complications with PDT were significantly associated with use of a bronchoscope (odds ratio, 6.7; 95% CI, 1.3-43.4; P = .04). The rate of complications was 1.9% in the no-bronchoscope cohort and 11.9% in the bronchoscope-assisted cohort (P = .05). The mean (SD) length of hospital stay was not significantly different between the 2 groups (51.4 [49.4] days in the no-bronchoscope cohort vs 46.9 [28.6] days in the bronchoscope-assisted cohort; P = .58).
Percutaneous dilational tracheostomy can be performed with similarly low complication rates with or without the use of bronchoscopy. Discontinuing the use of bronchoscopy in these procedures appears to be a safe, cost-effective alternative with reassuring outcomes and low complication rates.
改良经皮扩张气管切开术(PDT)是一种相对较新的替代方法,在该方法中,对覆盖气管的组织进行解剖,但仍盲穿入针。许多中心使用支气管镜辅助 PDT,但改良 PDT 是否需要支气管镜的协助尚未得到检验。与支气管镜辅助 PDT 相比,停止该程序的支气管镜检查可以潜在地降低成本并提高效率,同时获得相似的结果。
评估在 PDT 中放置支气管镜的必要性。
设计、设置和参与者:这是一项单中心、回顾性队列研究,纳入了 2007 年 5 月 1 日至 2015 年 2 月 1 日期间在一家三级护理机构接受 PDT(有或无支气管镜协助)的 149 例患者,数据分析于 2015 年 4 月 15 日至 5 月 1 日进行。
改良 PDT(有或无支气管镜协助)。
主要研究结局是术后并发症和气管切开术所在住院期间的住院时间。
在研究期间接受改良 PDT 且符合纳入标准的 149 例患者中,107 例在无支气管镜组(66 [61.7%]为男性;平均 [标准差]年龄,56.0 [18.7] 岁),42 例在支气管镜辅助组(26 [61.9%]为男性;平均 [标准差]年龄,58.0 [15.7] 岁)。PDT 相关并发症与支气管镜的使用显著相关(比值比,6.7;95% CI,1.3-43.4;P = .04)。无支气管镜组的并发症发生率为 1.9%,支气管镜辅助组为 11.9%(P = .05)。两组的平均(标准差)住院时间无显著差异(无支气管镜组为 51.4 [49.4] 天,支气管镜辅助组为 46.9 [28.6] 天;P = .58)。
PDT 可在不使用支气管镜的情况下以相似的低并发症发生率进行,停止这些操作中支气管镜的使用似乎是一种安全、具有成本效益的替代方法,具有令人安心的结果和低并发症发生率。